![Hands typing on keyboard](/images/574d2132-1b68-4631-b946-a015b1193524/dt/Media.jpg)
Media
Media
Our latest press releases
Hansa Biopharma: increase in number of shares and votes
Regulatory press release
28/06/2024
Bulletin from the Annual General Meeting in Hansa Biopharma AB (publ)
Regulatory press release
27/06/2024
Hansa Biopharma publishes prospectus for admission to trading of shares on Nasdaq Stockholm
Regulatory press release
07/06/2024
Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial
Regulatory press release
31/05/2024
Media
News and insights
A concerted collaboration to advance treatment options for people living with rare diseases
26/06/2024
Fueling the future: the role of biotech in advancing innovative science and delivering new medicines
02/05/2024
Addressing barriers to gene therapy treatment
31/01/2024
At the intersection of patient-centered care and disruptive science
24/10/2023
![Coffee and notepad](/images/b347e6a8-1cb0-41f3-82cd-1610d9cca8dd/ta-l/hansa-mockup-email.png)